The Lithium Gold Rush Just Minted a Unicorn This Year
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
What People Get Wrong About Retirement Planning
Identifying common mistakes in retirement planning can save you from future pitfalls. Learn what to avoid for a secure retirement.
14,327 articles
Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Canopy Growth Restating Years: What Investors Should Do Now
Canopy Growth is restating two years of earnings ahead of June earnings. This article breaks down what it means, how ...
Helix Partners Exits Reported: Cinemark Implications
A recent SEC filing details Helix Partners exiting its Cinemark stake. This article breaks down what that exit means ...
Is Salesforce Down More Than This? An AI Stock Insight
Salesforce’s AI roadmap has captivated many, but the stock has faced a steep pullback. This article weighs the bulls’...
Hims Hers Stock Undervalued: A Deep Dive Into Valuation
Hims & Hers has shown volatility, but can the stock be undervalued? This guide breaks down the business, key risks, a...
Hewlett Packard Enterprise Shares Rise on AI Demand Surge
Hewlett Packard Enterprise shares have climbed as demand for AI infrastructure accelerates. This article breaks down ...
Massive News: Iren's $4.4 AI Target Reshapes Markets
Iren is pursuing a bold AI infrastructure push with a $4.4 billion target. This article breaks down what that means f...
Down 37% Holdings Stock: Is Nu Holdings a Bargain Now
Nu Holdings has fallen sharply, with the stock down 37% from its 52-week high. This guide explains what an investor s...
280% YTD, Will AMD’s Rally Continue in 2026?
AMD has ridden a steep year-to-date surge powered by AI and cloud demand. Analysts warn the rally faces hurdles, but ...
AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Marvell Price Prediction: The Case for Double-Digit Upside
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status